Bradykinin Receptor

缓激肽受体 (Bradykinin Receptor) 是细胞表面的 G 蛋白偶联受体 (GPCR) 家族成员。缓激肽受体有两种亚型,B1 和 B2。缓激肽受体介导的信号转导在维持心血管稳态、调节疼痛和炎症方面发挥着重要作用。两种受体都通过激活 G 蛋白传递细胞外信号。

缓激肽 B1 受体在健康组织中的表达水平非常低,但在休克或炎症等应激条件下会被诱导,而缓激肽 B2 受体则无处不在且呈组成性表达。缓激肽 B2 受体参与血管舒张、渗透调节、平滑肌收缩和伤害感受器激活。缓激肽 B1 受体和缓激肽 B2 受体已成为治疗靶点,因为它们与炎症性疾病、血管病变、神经病变、肥胖症、糖尿病和癌症有关。B1R 和 B2R 在疾病中可发挥两种不同的作用。激动剂和拮抗剂已被评估为治疗剂。

Bradykinin receptors are cell surface, G protein-coupled receptor (GPCR) family members. There are two subtypes of bradykinin receptors, B1 and B2. Bradykinin receptor-mediated signal transductions play a significant role in maintaining cardiovascular homeostasis, regulating pain and inflammation. Both receptors transduce extracellular signals through the activation of G-proteins.

Bradykinin B1 receptor is expressed at a very low level in healthy tissues, but is induced under stressful conditions such as shock or inflammation, whereas the bradykinin B2 receptor is ubiquitous and is constitutively expressed. Bradykinin B2 receptor is involved in vasodilation, osmoregulation, smooth muscle contraction, and nociceptor activation. Bradykinin B1 receptor and Bradykinin B2 receptor have emerged as therapeutic targets as they are implicated in inflammatory disease, vasculopathy, neuropathy, obesity, diabetes, and cancer. B1R and B2R can hold dichotomous roles in diseases. Agonists and antagonists have been evaluated as therapeutics.

共 1种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
Thrombostatin cont-1

Thrombostatin cont-1 是一种凝血抑制素类似物,也是一种缓激肽代谢物,而凝血抑制素可降低犬颈动脉球囊成形术损伤模型中的血小板活化。

929555-19-1
Control
Thrombostatin cont-1

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础